1. Home
  2. ADUS vs XNCR Comparison

ADUS vs XNCR Comparison

Compare ADUS & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addus HomeCare Corporation

ADUS

Addus HomeCare Corporation

HOLD

Current Price

$119.33

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$26.37

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADUS
XNCR
Founded
1979
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
ADUS
XNCR
Price
$119.33
$26.37
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$133.78
$22.33
AVG Volume (30 Days)
165.6K
1.3M
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
23.40
65.36
EPS
2.85
N/A
Revenue
N/A
$125,576,000.00
Revenue This Year
$9.17
N/A
Revenue Next Year
$4.70
$4.80
P/E Ratio
$41.46
N/A
Revenue Growth
N/A
13.65
52 Week Low
$87.95
$8.29
52 Week High
$124.44
$30.61

Technical Indicators

Market Signals
Indicator
ADUS
XNCR
Relative Strength Index (RSI) 56.96 57.44
Support Level $114.12 $11.20
Resistance Level $121.73 $30.61
Average True Range (ATR) 2.80 1.71
MACD -0.62 -0.33
Stochastic Oscillator 55.78 45.14

Price Performance

Historical Comparison
ADUS
XNCR

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: